Predischarge Prediction of Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Derivation and Validation of a Risk Prediction Score

por Rieser, Caroline J., Hall, Lauren B., Kang, Eliza, Zureikat, Amer H., Holtzman, Matthew P., Pingpank, James F., Bartlett, David L., Choudry, M. Haroon A.
Publicado 2021

Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab

por Tarhini, Ahmad A., Edington, Howard, Butterfield, Lisa H., Lin, Yan, Shuai, Yongli, Tawbi, Hussein, Sander, Cindy, Yin, Yan, Holtzman, Matthew, Johnson, Jonas, Rao, Uma N. M., Kirkwood, John M.
Publicado 2014

Impact of genomic profiling on the treatment and outcomes of patients with advanced gastrointestinal malignancies

por Dhir, Mashaal, Choudry, Haroon A., Holtzman, Matthew P., Pingpank, James F., Ahrendt, Steven A., Zureikat, Amer H., Hogg, Melissa E., Bartlett, David L., Zeh, Herbert J., Singhi, Aatur D., Bahary, Nathan
Publicado 2016

Impact of Socioeconomic Status on Presentation and Outcomes in Colorectal Peritoneal Metastases Following Cytoreduction and Chemoperfusion: Persistent Inequalities in Outcomes at a...

por Rieser, Caroline J., Hoehn, Richard S., Zenati, Mazen, Hall, Lauren B., Kang, Eliza, Zureikat, Amer H., Lee, Andrew, Ongchin, Melanie, Holtzman, Matthew P., Pingpank, James F., Bartlett, David L., Choudry, M. Haroon A.
Publicado 2021

Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire

por Tarhini, Ahmad, Lin, Yan, Lin, Huang, Rahman, Zahra, Vallabhaneni, Priyanka, Mendiratta, Prateek, Pingpank, James F., Holtzman, Matthew P., Yusko, Erik C., Rytlewski, Julie A., Rao, Uma N. M., Ferris, Robert L., Kirkwood, John M.
Publicado 2018